Molecular Diagnostics
Cell-free RNA Profiles Gauge Preeclampsia Risk Months Before Symptoms
The period from conception to delivery represents the most rapid growth and development in an individual’s life. The ability to support this development requires dramatic and inadequately understood alterations in maternal physiology. More...18 Jan 2022
MCDA-LFB Assay Developed for Rapid Detection of Legionnaires’ Disease
Legionella pneumophila is an opportunistic waterborne pathogen of significant public health problems, which can cause serious human respiratory diseases (Legionnaires’ disease). Legionnaires’ disease is characterized by severe lung infection symptoms, including severe pneumonia with a high fatality rate. More...18 Jan 2022
Tumor Biomarker Panel Improves Identification of Candidates for Lung Cancer Screening
Use of a blood-based tumor biomarker panel in combination with modeling according to results of PLCOm2012 (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial) significantly improved risk assessment for lung cancer screening. More...17 Jan 2022
Meridian Receives FDA Clearance for Rapid Fluorescent Immunoassay for Detection of Campylobacter Infection
Meridian Bioscience, Inc. (Cincinnati, OH, USA) has received U.S. Food and Drug Administration (FDA) clearance for its Curian Campy assay developed to be utilized on the Curian immunofluorescent testing platform. More...14 Jan 2022
ddPCR Developed for BCR-ABL1 Fusion Transcript in B-Lymphoblastic Leukemia
Droplet digital polymerase chain reaction (ddPCR) is a novel polymerase chain reaction (PCR) technique reliant on massive sample partitioning to generate individual reaction chambers (droplets) in which individual amplification targets are detected. More...12 Jan 2022
Long Mononucleotide Repeat Markers Validated for Microsatellite Instability Detection
Mismatch repair deficiency (dMMR) predicts response to immune checkpoint inhibitor therapy in solid tumors. Long mononucleotide repeat (LMR) markers may improve the interpretation of microsatellite instability (MSI) assays. More...12 Jan 2022
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Blood Culture Identification Fungal Pathogen Panel
cobas eplex BCID-FP panel
New
Clostridium Difficile Assay
Revogene C. Difficile
In Other News
Commercial RT-PCR Tests Compared to Culture for Bacterial Gastroenteritis
A Novel Lateral Flow Immunoassay System for Determination of Prostate Specific Antigen
New Color-Coded Test Quickly Reveals If Medical Nanoparticles Deliver Their Payload into Target Cells
Novel Protein Biomarkers Identified for Prostate Cancer Aggressiveness
Menstrual Blood Testing With Capture Sequencing Detects High-Risk Human Papillomavirus
Sex Hormone–Binding Globulin Is a Biomarker for Cardiovascular Disease Risk Independent of Total Testosterone Concentration
Parkinson’s Disease Patients Have More Inflammatory Bacteria in Their Noses
Certain Protein Ectodomains in Cerebrospinal Fluid Are Diagnostic Biomarkers for Autism
Bacterial Communities Diverge in The Lower Airways of CF Children
Intratumor Heterogeneity Analyzed in Neuroblastoma
Epigenetic Biomarkers for Early Rheumatoid Arthritis Detection
Genomic Screening Can Identify Risk for Amyloid Cardiomyopathy
Cheek Swab Test Could Identify Biomarkers for Rheumatoid Arthritis
Rapid Biopsy Approach Shortens Time Required to Diagnose HPV-linked Head and Neck Cancers
Targeted RNA-Sequencing Panel Detects Gene Fusions in Solid Tumors
A Device for Rapid and Accurate Diagnosis of Hepatitis C Infections
Biomarker Predicts Potential Benefit of Checkpoint Inhibitor Therapy for Brain Cancer Patients
Same Day Test Identifies Secondary Infections in COVID-19 Patients
A Rapid and Sensitive Lateral Flow Test for Diagnosis of Schistosomiasis
First One-Hour, Direct-from-Blood Sepsis Test Receives FDA Clearance
Liquid Biopsy Predicts Therapy Response in Patients with Late-Stage Throat Cancer
Serum MicroRNA Panel Predict P-Tau/Aβ42 in CSF in Alzheimer's Disease
Biomarkers Predict Disease Progression for Patients with Late-stage Brain Tumors
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
